Publication

The selective peroxisome proliferator‐activated receptor gamma modulator CHS‐131 improves liver histopathology and metabolism in a mouse model of obesity and nonalcoholic steatohepatitis

Hepatology Communications 4(9):1302-1315, 2020

Perakakis P, Joshi A, Peradze N, Stefanakis K,Li G, Feigh M, Veidal SS, Rosen G, Fleming M, Mantzoros CS

Share this page

Resource Library

Related resources

Preclinical efficacy and clinical translatability of obeticholic acid in the GAN diet-induced obese and biopsy-confirmed mouse model of NASH

Metabolic, biochemical and histological effects of elafibranor in a CDAA-HFD induced non-obese rat model of advanced NASH with progressive fibrosis

Hepatoprotective effects of semaglutide in the diet-induced obese Ldlr-/- mouse model of NASH

Disease progression in the non-obese CDAA-HFD mouse model of advanced NASH and fibrosis

For further information

Contact us

Gubra

Hørsholm Kongevej 11B
2970 Hørsholm
Denmark

+45 3152 2650